“…N -Heterocycles such as thiazole and triazole are privileged scaffolds in drug discovery programs, with diverse pharmacological activity. , Similarly, thiazole or triazole fused with other heterocycles have been investigated against various diseases. , The condensed heterocycle of thiazole and triazole is termed as thiazolotriazole and exists in three isomeric forms: thiazolo[2,3- c ][1,2,4]triazole, thiazolo[3,2- b ][1,2,4]triazole and isothiazolo[3,2- c ][1,2,4]triazole . A wide range of pharmacological activities like anticancer, − antimicrobial, − anti-inflammatory, analgesic, antidiuretic, and COX 2 inhibition were reported for thiazolotriazoles; major efforts in research were focused on antimicrobial drug design, with the [3,2- b ] ring system being widely investigated when compared to the [2,3- c ] ring system (Figure ); however, the proven or suggested mode of action or drug targets are not well established for any of the thiazolotriazole-based antimicrobials. In antitubercular drug research, the thiazolotriazoles have not been widely investigated (Figure ).…”